VIDEO: TP-03 safe, effective in treating Demodex blepharitis

ByPaul M. Karpecki, OD, FAAO

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Results from two trials showed that TP-03 was well-tolerated and efficacious in reducing collarettes and Demodex density through 90 days in patients with Demodex blepharitis.

In this video, Paul Karpecki, OD, FAAO, speaks at the virtual American Academy of Optometry virtual meeting about the MARS open-label clinical trial and JUPITER randomized control trial.